Prepubertal gynecomastia is not always idiopathic: case series and review of the literature.
Laimon W, El-Hawary A, Aboelenin H, Elzohiri M, Abdelmaksoud S, Megahed N, Salem N.
Eur J Pediatr. 2021 Mar;180(3):977-982. doi: 10.1007/s00431-020-03799-x. Epub 2020 Sep 25.
Gynecomastia: A systematic review of pharmacological treatments.
Berger O, Landau Z, Talisman R.
Front Pediatr. 2022 Nov 1;10:978311. doi: 10.3389/fped.2022.978311. eCollection 2022.
Gynecomastia.
Vandeven HA, Pensler JM.
2023 Aug 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Adolescent Gynecomastia.
Guss CE, Divasta AD.
Pediatr Endocrinol Rev. 2017 Jun;14(4):371-377. doi: 10.17458/per.vol14.2017.GD.Gynecomastia.
Tamoxifen in men: a review of adverse events.
Wibowo E, Pollock PA, Hollis N, Wassersug RJ.
Andrology. 2016 Sep;4(5):776-88. doi: 10.1111/andr.12197. Epub 2016 May 6.
Prepubertal Idiopathic Unilateral Gynecomastia: Case Report and Literature Review.
Herbert SL, Ergezinger K, Sauer S, Kurz F, Schlaiß T, Wöckel A, Albert US.
Breast Care (Basel). 2022 Dec;17(6):573-579. doi: 10.1159/000525096. Epub 2022 May 17.
Is There a Rationale behind Pharmacotherapy in Idiopathic Gynecomastia?
Kasielska-Trojan A, Danilewicz M, Antoszewski B.
Horm Res Paediatr. 2018;89(6):408-412. doi: 10.1159/000487753. Epub 2018 May 17.
Idiopathic prepubertal unilateral gynecomastia: Case report and literature review.
Wang C, Yu N, Zhu L, Zeng A.
Medicine (Baltimore). 2019 Oct;98(40):e17374. doi: 10.1097/MD.0000000000017374.
The role of steroid receptors, peptides and growth factors in the aetiopathogenesis of idiopathic gynecomastia.
Singh VP, Das L, Kumar P, Bal A, Gaba S, Tripathy S, Dutta P.
Andrologia. 2022 Jul;54(6):e14414. doi: 10.1111/and.14414. Epub 2022 Mar 16.
Unraveling the Enigma: A Rare Case of Recurrent Idiopathic Gynecomastia in an Adolescent.
Jabori SK, Hullfish H, Samaha Y, Becker H, Thaller SR.
J Craniofac Surg. 2024 Jan-Feb 01;35(1):208-210. doi: 10.1097/SCS.0000000000009852. Epub 2023 Nov 22.
